-
The Other Shoe Drops: uniQure Shares Plans To Submit Licensing Application With The FDA for AMT-130
Latest News
-
Coming soon from the 2013 Huntington's Disease World Congress: Buzzilia!
HDBuzz presents 'Buzzilia!', our reports from the 2013 HD World Congress in Rio de Janeiro, from Sun 15 September
-
Could muscle problems help explain movements in Huntington’s Disease patients?
Proper contraction of muscles is crucial for coordination; errors in this process might help explain movements in HD
-
The 2013 HDBuzz Prize for Young Science Writers
Announcing the 2013 HDBuzz Prize for Young Science Writers!
-
Does a 'rusty hinge' cause Huntington's disease?
Canadian scientists have found that the mutant huntingtin protein is less flexible than normal.
-
How long is too long? Rethinking the Huntington’s disease ‘gray area’
Does an ‘intermediate’ CAG repeat count in the Huntington’s disease gene cause brain changes?
-
Can sad mice help treat Huntington's disease?
What can we learn about depression symptoms in HD by studying mice – how do you know a mouse is even sad?
-
Gene silencing drug safe in ALS patients… bring on Huntington's disease trials
Gene silencing drug injected into spinal fluid in ALS patients proves safe. Good news for similar planned HD trials.
-
A DNA repair protein modifies the stability of long CAG tracts in the Huntington's disease gene
DNA repair is a critical process to cells, but errors in this process might explain 'repeat instability' in HD
-
Landmark study puts Huntington's disease trials on TRACK
Final results from the TRACK-HD study show very specific changes in HD. We're ready for trials: bring on the drugs!
-
Splicing with danger: a new way of thinking about the harmful Huntington's disease protein
Researchers discover a new way harmful fragments of the huntingtin protein are made in neurons.
HDBuzz Trial Tracker
Sites for Phase 3 trial for votoplam, INVEST-HD, now open. Updates on recruitment and first dosing imminent.
REGEN4HD, Phase 1 stem cell implantation study commences
Progress update for NCT06585449 – A Study to Evaluate ALN-HTT02
